LEADER 01708nam  2200397Ia 450 
001 9910696648603321
005 20080610093010.0
035   $a(CKB)5470000002380376
035   $a(OCoLC)231620845
035   $a(EXLCZ)995470000002380376
100   $a20080610d2008      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPrescription drugs$b[electronic resource] $etrends in FDA's oversight of direct-to-consumer advertising : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /$fstatement of Marcia Crosse
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2008]
215   $a15 pages $cdigital, PDF file
225 1 $aTestimony ;$vGAO-08-758 T
300   $aTitle from title screen (viewed on June 3, 2008).
300   $a"For release ... May 8, 2008."
300   $aPaper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
320   $aIncludes bibliographical references.
517   $aPrescription drugs 
606   $aDirect-to-consumer prescription drug advertising$zUnited States
615  0$aDirect-to-consumer prescription drug advertising
700   $aCrosse$b Marcia$01380679
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Energy and Commerce.$bSubcommittee on Oversight and Investigations.
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910696648603321
996   $aPrescription drugs$93427483
997   $aUNINA